Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:8,9-EpETrE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002758 AN004477 Metabolic responses of normal rat kidneys to a high salt intake (Plasma) Blood Rat Medical College of Wisconsin Area
ST002761 AN004487 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin Area
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago intensity
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo ng/mg tissue
ST002582 AN004253 MoTrPAC: Endurance exercise training study in young adult rats, Rat Plasma - Targeted Oxylipins Blood Rat Emory University ng/uL
ST002596 AN004268 MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Targeted Oxylipins Gastrocnemius Rat Emory University ng/uL
ST002602 AN004274 MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Targeted Oxylipins Heart Rat Emory University ng/uL
ST002606 AN004278 MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Targeted Oxylipins Kidney Rat Emory University ng/uL
ST002610 AN004282 MoTrPAC: Endurance exercise training study in young adult rats, Rat Lung Powder - Targeted Oxylipins Lung Rat Emory University ng/uL
ST002616 AN004288 MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Targeted Oxylipins Liver Rat Emory University ng/uL
ST002626 AN004298 MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Targeted Oxylipins White adipose Rat Emory University ng/uL
ST001154 AN001946 A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium Blood Mouse University of California nM
ST001845 AN002988 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part IV) Blood Human Fatty liver disease University of California, Davis nM
ST002001 AN003264 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 2) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University nM
ST002767 AN004503 Metabolomic analysis of maternal mid-gestation plasma and cord blood: oxylipins Blood Human Autism Columbia University nM
ST002800 AN004556 Hepatic oxylipin profiles in mouse models of Wilson disease: new insights into early hepatic manifestations. Liver Mouse Wilson disease University of California, Davis nM
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center - Harvard Medical School Peak area
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center - Harvard Medical School Peak area
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center - Harvard Medical School Peak area
ST003063 AN005018 Uncoupling Metabolic Health from Thermogenesis via BCAA Nitrogen Flux in Brown Fat - Serum metabolomics from control and MBC UCP1-KO Blood Mouse Diabetes BIDMC Peak area
ST001124 AN001849 Early Mechanistic Events Induced by Secondhand Smoke Prevalent Low Molecular Weight Polycyclic Aromatic Hydrocarbons in Mouse Lung Epithelial Cells Epithelial cells Mouse Lung disease University of Colorado Anschutz Medical Center pg per 1.5 million cells
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
  logo